miR-802
rnamiR-802 upregulation amplifies endothelial inflammation and plaque destabilization in Type 1 MI, particularly in MINOCA phenotypes.
Pathway placement
Cascade stepPlaque inflammation
Confidencemedium
RationalePro-inflammatory microRNA in MINOCA; regulates inflammatory mediators.
Druggability
Not assessed (no mapped human gene target).
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Whole blood or cell-free plasma
Collection tube
PAXgene/Tempus RNA tube · K2/K3-EDTA (lavender-top)
Method / principle
RT-qPCR (TaqMan) or small-RNA sequencing
Reagent / substrate
Target-specific primers/probe; reverse transcriptase (miRNA: stem-loop RT primer)
Platform
qPCR instrument / NGS
Turnaround · availability
Research / send-out · Research (few LDTs)
Literature evidence(1)
- Molecular screening in a translational large animal trial identifies a differential inflammatory response for MINOCA.Basic research in cardiology · 2025 · PMID 40512240 · doi